Find all
associated with


Refine your query (more in Advanced-Search):
 Focus on the recent 5 years   Focus on the current year   Focus on the last 30 days   More choices ...
 Focus on articles with free fulltexts   More choices ...
 Do simple 'keyword' search (no query expansion)

[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 1211476
1. Alnemri AM: Black lung persistent pulmonary hypertension of the newborn. Saudi experience with sildenafil and nitric oxide. Saudi Med J; 2017 Jan;38(1):97-100
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Black lung persistent pulmonary hypertension of the newborn. Saudi experience with sildenafil and nitric oxide.
  • OBJECTIVES: To determine the clinical presentation, risk factors, diagnosis, and treatment outcome of Saudi infants with black lung persistent pulmonary hypertension of the newborn (PPHN).
  • Only one infant required mechanical ventilation and inhaled nitric oxide in addition to oral sildenafil.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28042638.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Saudi Arabia
  •  go-up   go-down


2. Maccallini C, Amoroso R: Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders. Neural Regen Res; 2016 Nov;11(11):1731-1734
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders.
  • In this short review we analyze some promising advancements in the search of new bioactive molecules targeting neuronal nitric oxide synthase (nNOS), an enzyme deputed to the biosynthesis of nitric oxide (NO).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Pharmacol. 2013 Aug;169(7):1417-29 [23617570.001]
  • [Cites] Nat Med. 2010 Dec;16(12 ):1439-43 [21102461.001]
  • [Cites] ChemMedChem. 2016 Aug 19;11(16):1695-9 [27377568.001]
  • [Cites] J Med Chem. 2012 Jan 26;55(2):943-55 [22175766.001]
  • [Cites] Clin Ther. 2010 Jan;32(1):146-60 [20171420.001]
  • [Cites] J Neurosci. 1999 Dec 1;19(23):10250-61 [10575022.001]
  • [Cites] Science. 2002 Oct 25;298(5594):846-50 [12399596.001]
  • [Cites] Springerplus. 2016 May 17;5:637 [27330903.001]
  • [Cites] Mini Rev Med Chem. 2013 Jul;13(9):1305-10 [23621655.001]
  • [Cites] Bioorg Med Chem Lett. 2012 Mar 1;22(5):1980-4 [22318159.001]
  • [Cites] Front Cell Neurosci. 2015 Aug 17;9:322 [26347610.001]
  • [Cites] Brain Res Bull. 2016 Jul;125:99-105 [27237129.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):117-26 [15631993.001]
  • [Cites] Br J Pharmacol. 2013 Mar;168(5):1255-65 [23072468.001]
  • [Cites] J Med Chem. 2015 Feb 12;58(3):1064-6 [25602734.001]
  • (PMID = 28123402.001).
  • [ISSN] 1673-5374
  • [Journal-full-title] Neural regeneration research
  • [ISO-abbreviation] Neural Regen Res
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] India
  • [Keywords] NOTNLM ; NMDAR / PSD95 / amidines / carbonic anhydrase / inhibitors / neurological diseases / neuronal nitric oxide synthase
  •  go-up   go-down


3. Guillen-Del Castillo A, Sánchez-Vidaurre S, Simeón-Aznar CP, Cruz MJ, Fonollosa-Pla V, Muñoz X: Prognostic Role of Exhaled Breath Condensate pH and Fraction Exhaled Nitric Oxide in Systemic Sclerosis Related Interstitial Lung Disease. Arch Bronconeumol; 2016 Dec 27;
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic Role of Exhaled Breath Condensate pH and Fraction Exhaled Nitric Oxide in Systemic Sclerosis Related Interstitial Lung Disease.
  • [Transliterated title] Valor pronóstico del pH en el condensado de aire exhalado y de la fracción exhalada de óxido nítrico en la enfermedad pulmonar intersticial asociada a esclerosis sistémica.
  • METHODS: Fraction exhaled nitric oxide (FeNO) and exhaled carbon monoxide (eCO) measured in EB, together with pH, nitrite, nitrate and interleukin-6 levels measured in EBC were prospectively analyzed in 35 patients with SSc.
  • EB and EBC biomarkers were determined at inclusion, and pulmonary function tests were annually performed during 4 years of follow-up.
  • In all patients studied, low EBC pH levels were associated with a decreased diffusing capacity for carbon monoxide (DLCO) during follow-up.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.
  • (PMID = 28038794.001).
  • [ISSN] 1579-2129
  • [Journal-full-title] Archivos de bronconeumologia
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] eng; spa
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  • [Keywords] NOTNLM ; Aire exhalado / Enfermedad pulmonar intersticial / Esclerosis sistémica / Exhaled breath / Interstitial lung disease / Nitric oxide / Systemic sclerosis / pH / Óxido nítrico
  •  go-up   go-down


Advertisement
4. Deng DD, Zhou AY, Shuang QC, Chen P: [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome]. Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb 12;40(2):98-101
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
  • : <b>Objective:</b> To explore the diagnostic value of fractionated exhaled nitric oxide (FeNO) measurement in patients with asthma-chronic obstructive pulmonary disease(COPD) overlap syndrome (ACOS).
  • <b>Methods:</b> Eighty-one patients with ACOS, 76 patients with asthma, 82 patients with COPD and 39 healthy non-smoking subjects were recruited in the study.
  • Pulmonary function was also measured.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28209039.001).
  • [ISSN] 1001-0939
  • [Journal-full-title] Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
  • [ISO-abbreviation] Zhonghua Jie He He Hu Xi Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Keywords] NOTNLM ; Asthma / Asthma-COPD overlap syndrome / Nitric oxide / Pulmonary disease, chronic obstructive
  •  go-up   go-down


5. Cao Z, Mathai SC, Hummers LK, Shah AA, Wigley FM, Lechtzin N, Hassoun PM, Girgis RE: Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis. Pulm Circ; 2016 Dec;6(4):545-550
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis.
  • : The fractional exhaled concentration of nitric oxide (FE<sub>NO</sub>) has been shown to be reduced in idiopathic pulmonary arterial hypertension (PAH) but has not been adequately studied in PAH associated with systemic sclerosis (SSc).
  • We measured FE<sub>NO</sub> at an expiratory flow rate of 50 mL/s in 21 treatment-naive patients with SSc-associated PAH (SSc-PAH), 94 subjects with SSc without pulmonary involvement, and 84 healthy volunteers.
  • Measurements of FE<sub>NO</sub> at additional flow rates of 100, 150, and 250 mL/s were obtained to derive the flow-independent nitric oxide exchange parameters of maximal airway flux (J'aw<sub>NO</sub>) and steady-state alveolar concentration (CA<sub>NO</sub>).
  • Increased alveolar nitric oxide in SSc-PAH likely represents impaired diffusion into pulmonary capillary blood.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28090297.001).
  • [ISSN] 2045-8932
  • [Journal-full-title] Pulmonary circulation
  • [ISO-abbreviation] Pulm Circ
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; exhaled nitric oxide / pulmonary arterial hypertension / scleroderma / systemic sclerosis
  •  go-up   go-down


6. Zeng WP, Zhang R, Li R, Luo JF, Hu XF: Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent. PLoS One; 2017;12(1):e0170964
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
  • Genotyping was performed on six single nucleotide polymorphisms (SNPs) in the endothelial nitric oxide synthase gene (eNOS), the angiotensin converting enzyme gene (ACE), the angiotensin II type 1 receptor gene (AT1R), the transforming growth factor beta gene (TGF-β), and the vascular endothelial growth factor gene (VEGF).
  • Of the six analyzed SNPs, the frequency of the C allele of T786C polymorphism in eNOS was significantly higher in the ISR group (22.2%) compared to the non-ISR group (12.7%) (p<0.01).
  • In the ISR group, the frequency of the TT, TC, and CC genotypes was 61.1%, 33.3%, and 5.6%, respectively, and in the non-ISR group, the frequencies were 76.8%, 21.0%, and 2.2%, respectively.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Circulation. 1999 Jun 8;99(22):2864-70 [10359729.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1769-76 [12426203.001]
  • [Cites] N Engl J Med. 1995 Mar 16;332(11):706-11 [7854377.001]
  • [Cites] Hum Mol Genet. 2000 Nov 1;9(18):2629-37 [11063722.001]
  • [Cites] Eur Heart J. 2002 Dec;23(24):1955-62 [12473258.001]
  • [Cites] Histochem Cell Biol. 2001 Dec;116(6):471-81 [11810189.001]
  • [Cites] J Am Coll Cardiol. 2002 Dec 18;40(12):2072-81 [12505216.001]
  • [Cites] Circulation. 1997 Jul 1;96(1):56-60 [9236417.001]
  • [Cites] Int J Clin Exp Pathol. 2015 Jun 01;8(6):7350-7 [26261635.001]
  • [Cites] N Engl J Med. 1994 Aug 25;331(8):496-501 [8041414.001]
  • [Cites] JAMA. 2007 Jan 10;297(2):159-68 [17148711.001]
  • [Cites] PLoS One. 2012;7(5):e37878 [22662243.001]
  • [Cites] Clin Chim Acta. 2006 Mar;365(1-2):86-92 [16157324.001]
  • [Cites] Heart. 2014 Jan;100(2):153-9 [24270744.001]
  • [Cites] J Am Coll Cardiol. 2006 Jul 4;48(1):193-202 [16814667.001]
  • [Cites] Cardiovasc Res. 2008 Jan;77(1):19-29 [17658499.001]
  • [Cites] Circulation. 2004 Feb 10;109(5):634-40 [14769686.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2832-5 [10717002.001]
  • [Cites] J Card Fail. 2010 Apr;16(4):314-9 [20350698.001]
  • [Cites] PLoS One. 2014 Nov 19;9(11):e113363 [25409023.001]
  • [Cites] Angiology. 2015 Aug;66(7):652-8 [25155040.001]
  • [Cites] Am J Cardiol. 2000 Sep 15;86(6):628-34 [10980213.001]
  • [Cites] Hum Mol Genet. 2002 Feb 1;11(3):229-41 [11823442.001]
  • [Cites] Int J Cardiol. 2002 Nov;86(1):71-6 [12243851.001]
  • [Cites] J Am Coll Cardiol. 2011 Mar 15;57(11):1314-22 [21376502.001]
  • [Cites] Medicine (Baltimore). 2016 May;95(19):e3413 [27175642.001]
  • [Cites] Exp Mol Pathol. 2015 Feb;98(1):13-7 [25449332.001]
  • [Cites] Pharmacogenet Genomics. 2006 May;16(5):331-7 [16609364.001]
  • [Cites] PLoS One. 2016 Mar 01;11(3):e0150500 [26930482.001]
  • [Cites] Thromb Res. 2007;119(5):579-85 [16842840.001]
  • [Cites] Eur Heart J. 2013 Nov;34(42):3304-13 [23824827.001]
  • [Cites] N Engl J Med. 2009 May 7;360(19):1933-45 [19420363.001]
  • [Cites] Circulation. 1998 Jan 20;97(2):147-54 [9445166.001]
  • [Cites] Clin Sci (Lond). 2007 Jul;113(2):47-63 [17555404.001]
  • [Cites] Atherosclerosis. 2007 Aug;193(2):438-44 [16938300.001]
  • [Cites] J Vasc Res. 2010;47(4):309-22 [20016205.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2006 May;26(5):1114-9 [16543493.001]
  • [Cites] Mol Cell Biochem. 2012 Nov;370(1-2):241-9 [22890915.001]
  • [Cites] Curr Opin Pharmacol. 2013 Apr;13(2):161-7 [23395155.001]
  • [Cites] J Pathol. 2000 Feb;190(3):244-54 [10685059.001]
  • [Cites] J Am Coll Cardiol. 2001 Nov 1;38(5):1434-9 [11691520.001]
  • [Cites] EuroIntervention. 2014 Jun;10 (2):224-30 [24168783.001]
  • [Cites] Pharmacology. 2010;85(4):211-6 [20215811.001]
  • (PMID = 28129392.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Wiwanitkit V: Nitric oxide synthase and polycystic kidney disease. J Nephropharmacol; 2015;4(2):85-87
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitric oxide synthase and polycystic kidney disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28197487.001).
  • [Journal-full-title] Journal of nephropharmacology
  • [ISO-abbreviation] J Nephropharmacol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Keywords] NOTNLM ; Chronic kidney disease / Nitric oxide synthase / Polycystic kidney disease
  •  go-up   go-down


8. Madhu BP, Singh KP, Saminathan M, Singh R, Shivasharanappa N, Sharma AK, Malik YS, Dhama K, Manjunatha V: Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice. Virusdisease; 2016 Dec;27(4):387-399
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice.
  • : Rabies virus (RABV) stimulates nitric oxide (NO) production, which either triggers T cell differentiation or suppresses T cell function depending on its concentration.
  • The experimental animals were divided into four groups and 100LD<sub>50</sub> of challenge virus standard (CVS) strain of RABV was inoculated intracerebrally on day 0 and subsequently aminoguanidine (AG; inducible nitric oxide synthase inhibitor) was injected intraperitoneally twice a day, up to 6 days.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28004019.001).
  • [ISSN] 2347-3584
  • [Journal-full-title] Virusdisease
  • [ISO-abbreviation] Virusdisease
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Keywords] NOTNLM ; Aminoguanidine / CD4+ / CD8+ T lymphocytes / Challenge virus standard strain / Natural killer cells / Rabies virus
  •  go-up   go-down


9. Parikh J, Kapela A, Tsoukias NM: Can endothelial Hemoglobin-alpha regulate Nitric Oxide vasodilatory signaling? Am J Physiol Heart Circ Physiol; 2017 Jan 27;:ajpheart.00315.2016
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Can endothelial Hemoglobin-alpha regulate Nitric Oxide vasodilatory signaling?
  • : We utilized mathematical modeling to investigate nitric oxide (NO)-dependent vasodilatory signaling in the arteriolar wall.
  • Detailed continuum cellular models of calcium (Ca<sup>2+</sup>) dynamics and membrane electrophysiology in smooth muscle (SMC) and endothelial cells (EC) were coupled with models of NO signaling and biotransport in an arteriole.
  • We use this theoretical approach to examine the role of endothelial hemoglobin alpha (Hbα) as a modulator of NO-mediated myoendothelial feedback as previously suggested in Straub al. (Nature 491: 473-477, 2012).
  • The model considers enriched expression of inositol 1,4,5- triphosphate receptors (IP<sub>3</sub>Rs), endothelial nitric oxide synthase (eNOS) enzyme, Ca<sup>2+</sup> activated potassium (K<sub>Ca</sub>) channels and Hbα in myoendothelial projections (MPs) between the two cell layers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016, American Journal of Physiology-Heart and Circulatory Physiology.
  • (PMID = 28130333.001).
  • [ISSN] 1522-1539
  • [Journal-full-title] American journal of physiology. Heart and circulatory physiology
  • [ISO-abbreviation] Am. J. Physiol. Heart Circ. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Calcium dynamics / compartmentalization / myoendothelial signaling / smooth muscle cell / vasorelaxation
  •  go-up   go-down


10. Del Rosso JQ, Kircik LH: Spotlight on the Use of Nitric Oxide in Dermatology: What Is It? What Does It Do? Can It Become an Important Addition to the Therapeutic Armamentarium for Skin Disease? J Drugs Dermatol; 2017 Jan 01;16(1):s4-s10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spotlight on the Use of Nitric Oxide in Dermatology: What Is It? What Does It Do? Can It Become an Important Addition to the Therapeutic Armamentarium for Skin Disease?
  • : Nitric oxide (NO) is a diatomic gas that is synthesized within and released by multiple host cell types functioning to provide a variety of physiologic and homeostatic effects.
  • Nitric oxide exhibits a variety of effects that relate significantly with outcomes that can provide therapeutic benefit if properly formulated and released.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28095537.001).
  • [ISSN] 1545-9616
  • [Journal-full-title] Journal of drugs in dermatology : JDD
  • [ISO-abbreviation] J Drugs Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement